首页
登录
职称英语
[originaltext] As companies increasingly test new drugs in other countries,
[originaltext] As companies increasingly test new drugs in other countries,
游客
2023-12-24
41
管理
问题
As companies increasingly test new drugs in other countries, they are struggling to decide what, if anything, they owe the patients who served as test subjects. Some companies have chosen not to sell their drugs in the countries where they were tested; others have marketed their drugs there, but few patients in those countries can afford them.
The issue is especially difficult when it comes to drugs that do not save lives but can vastly improve the quality of life. Nobody knows for sure how many patients in other countries have had to forgo drugs that improved their lives when clinical trials ended, and companies do not give out patients’ names, to protect their privacy. But the issue is very much on the minds of company researchers and executives.
Ethicists say that they, too, are troubled but that their field has reached no consensus on what companies should do. "Do we have an obligation to everyone in the trial or to everyone in the community, the province, the nation, the region of the world?" asked Dr. Ruth Faden, the director of the Phoebe R. Berman Bioethics Institute at Johns Hopkins University. "We haven’t really figured this out."
Yet, Dr. Faden said, "many physician investigators feel uncomfortable with the idea of using patients in studies and then not being able to continue to help them when the trial ends."
Companies must make business decisions about where to market their drugs, figuring out whether they can earn enough money to justify applying for approval, setting up business offices and hiring a sales force. If they decide not to market a drug in a given country, they are unlikely to provide it to patients there free of charge. To provide a drug for what medical professionals call compassionate use, companies must set up a distribution system, train doctors to administer the drugs, monitor patients for adverse effects and track the results.
Whether to undertake a compassionate-use program for drugs that improve the quality of life but do not prolong it poses "a delicate question", said Tony Plohoros, a spokesman for Merck, a company that has systems to distribute lifesaving drugs in poor countries where there is a need.
The issue is especially difficult for small companies that as yet have no products on the market. A small company cannot afford to set up a marketing system in countries where few can buy the drug, or a distribution system to give its drugs away.
In the United States, patients who participate in clinical trials often continue to receive the drug being tested until it is approved. After that, they can buy it or, if they cannot afford it, apply to special programs that most companies offer to help people who could not otherwise get drugs they need.
But with the exception of AIDS drugs, which companies provide free or at low cost to patients in poor countries, there is no industry consensus about what to do internationally, especially when drugs are not lifesaving. And even when companies market their drugs in poor countries, they tend not to set up a system to give the drugs away to study subjects after a clinical trial ends.
Ethicists acknowledge that companies are businesses and accountable to investors.
But on the other hand, Dr. Gostin said, there is something troubling about "parachute research", in which a company drops into a country, conducts its research and then leaves.
"It raises the question of what ethical obligation, if any, there might be to give back and make sure there is access to the drug after the trials are over," Dr. Gostin said.
The participants in a study take a risk to help a company determine if its drug is safe and effective, he said, and "it seems to me that there is an ethical obligation to give back."
选项
答案
1. As companies increasingly test new drugs in other countries, they are struggling to decide what they owe the patients who served as test subjects.
2. The issue is especially difficult when it comes to drugs that do not save lives but can vastly improve the quality of life.
3. Ethicists are troubled too, but they have reached no consensus on what companies should do.
4. Companies must make business decisions and figure out whether they can earn enough money to justify those decisions.
5. To provide a drug for compassionate use is costly and poses "a delicate question".
6. The issue is especially difficult for small companies because they simply can’t afford it.
7. In the U.S., patients who participate in clinical trials can often get drugs they need after the test.
8. But there is no industry consensus about what to do internationally, especially when drugs are not lifesaving.
9. Ethicists acknowledge that companies are businesses and accountable to investors.
10. But on the other hand, there is an ethical obligation to give back.
解析
转载请注明原文地址:https://tihaiku.com/zcyy/3302237.html
相关试题推荐
IhopethatothercountriesisenoughpowerfultorejectAmerica’snonsensedema
Mostpeopleinallcountriesconnectedwithair-trafficcontrolare______toadmi
"Whatisabsolutelyessentialistoseethatthedevelopedcountriesestablisha
Withcloud,mobility,bigdataandconsumerization,companiesareinevengre
Withcloud,mobility,bigdataandconsumerization,companiesareinevengre
Withcloud,mobility,bigdataandconsumerization,companiesareinevengre
Withcloud,mobility,bigdataandconsumerization,companiesareinevengre
Withcloud,mobility,bigdataandconsumerization,companiesareinevengre
Withcloud,mobility,bigdataandconsumerization,companiesareinevengre
Withcloud,mobility,bigdataandconsumerization,companiesareinevengre
随机试题
Anexperimentwasdoneinwhichhumansubjectsrecognizeapatternwithinamatr
[originaltext]W:Roger,anyproblemsinyourKoreanstudy?M:[5]Thebiggestpr
Suicide,thenumber-twokillerofcollegestudent,claimsthelivesofappro
[originaltext]Haveyoueverfoundyourselfinthissituation:Youhearaso
患者,女性,50岁。阵发性右下腹痛伴恶心、呕吐1天。肛门无排气。查体:腹平软,右
女,12岁,白血病,近日左眼眶出现2cm×2cm无痛性肿块。最可能是哪型白血病A
膀胱癌术后易复发,故术后需膀胱内灌注药物,灌注治疗一般为A.2次/周,连续6~8
如下图所示,直线AC从点A匀速下落至正下方点B。整个过程中,直线直线AC与扇形A
银行承兑汇票的承兑银行,应当按照票面金额向出票人收取()的手续费。A:千分之一
在城市市区噪声敏感区域内,禁止夜间进行产生噪声污染的施工作业,因特殊需要必须连续
最新回复
(
0
)